Genetic risk? new study aims to catch aggressive prostate cancer early

NCT ID NCT04472338

Recruiting now Knowledge-focused Sponsor: University of Washington Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looks for better ways to find aggressive prostate cancer early in people who have a genetic risk. Researchers will collect blood, urine, and tissue samples from 450 participants to learn more about the genetics of this disease. The goal is to improve future screening and treatment, not to test a new treatment itself.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PROSTATE CARCINOMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

prostate carcinoma prostate cancer prevention target

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

PROSTATE CARCINOMA

Contacts and locations

Show contact details

Locations

City of Hope
RECRUITING

Duarte, California, 91010, United States
Fred Hutch/University of Washington Cancer Consortium
RECRUITING

Seattle, Washington, 98109, United States
Massachusetts General Hospital
RECRUITING

Boston, Massachusetts, 02114, United States
Northwestern
RECRUITING

Chicago, Illinois, 60611, United States
OHSU Knight Cancer Institute
RECRUITING

Portland, Oregon, 97239, United States

Contact Email: •••••@•••••
University of California, San Francisco
RECRUITING

San Francisco, California, 94143, United States
University of Pennsylvania/Abramson Cancer Center
RECRUITING

Philadelphia, Pennsylvania, 19104, United States
University of Texas Health Science Center at San Antonio
TERMINATED

San Antonio, Texas, 78229, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.